Dry Eye – Can You Cry?
Abstract
Overview
Ocular surface discomfort is often attributed to the symptoms of dry eye, but conditions affecting the lacrimal gland are uncommon. Meibomian gland dysfunction (MGD) is extremely common and is a characteristic feature of many patients with dry eye symptoms. Most ophthalmologists choose some type of lubricant artificial tear drop as first-line treatment for dry eye symptoms, but this paper questions the rationale for this decision. Patients who can cry, or produce tears from any stimulus, demonstrate lacrimal gland function. This paper considers the rationale for employing a safe, effective, biodegradable warm compress as first-line treatment for MGD and associated dry eye symptoms.
Keywords
Dry eye, meibomian gland dysfunction, Sjögren syndrome, blepharitis, warm compress, EyeBag®, anthropocene
Article Information
Disclosure
Compliance with Ethics: This study involves a review of the literature and did not involve any studies with human or animal subjects performed by any of the authors. All images published with full patient consent and permissions. All photographs taken by the author.
Review Process
Double-blind peer review.
Authorship
The named authors meets the International
Committee of Medical Journal Editors (ICMJE) criteria
for authorship of this manuscript, takes responsibility
for the integrity of the work as a whole, and has given
final approval for the version to be published.
Correspondence
Teifi James, The EyeBag Company, Unit 5, Calderdale Business Park, Club Lane. Halifax, West Yorkshire, HX2 8DB, UK. E: eyebag@me.com
Support
No funding was received for the publication of this article.
Received
18 November 2019
Further Resources
Trending Topic
Dry eye disease (DED) is a prevalent ocular condition characterized by discomfort, visual disturbances and tear film instability due to insufficient tear production or rapid tear evaporation.1 With an increasing global incidence (i.e. up to 50%) and its significant impact on the quality of life, there is a growing need for accurate and efficient diagnostic methods to […]
Dry eye disease (DED) is a multifactorial condition of the ocular surface and tears. It is frequently encountered in ocular practices, comprising nearly 33% of visits in the USA, and with an estimated global prevalence ranging between 5% and 50%.1,2 The chronic symptoms ...
Reproxalap is a reactive aldehyde species (RASP) inhibitor believed to mitigate inflammatory conditions such as dry eye disease (DED), allergic conjunctivitis and uveitis.1 RASP are pro-inflammatory molecules that covalently bind to thiol and amino groups expressed on various receptors and ...
Demodex blepharitis is a highly prevalent lid margin disease that is commonly missed or misdiagnosed by eye care professionals. The disease is caused by an infestation of Demodex mites – tiny parasites that live in the eyelash follicles and feed on ...
The prevalence of both dry eye disease and sleep apnoea has steadily increased in the USA.1 Importantly, new research reveals the need for multispecialty collaboration based on evidence that patients may be at risk for eye irritation secondary to airflow ...
Dry eye disease (DED) is an inflammatory condition of the cornea and conjunctiva that is characterized by tear-film instability and increased tear osmolarity.1–3 While DED is traditionally viewed as a chronic condition, many patients experience episodic exacerbations of the disease, ...
Over the past few years, we have witnessed an increasing awareness of the importance of treating ocular surface disease (OSD). Diagnoses such as dry eye and blepharitis, which were historically under-appreciated, now command attention from the ophthalmologist and investment from ...
Dry eye disease is a chronic condition that affects the corneal surface, and is clinically characterized by loss of tear volume and increased evaporation of tears.1,2 The definition of dry eye disease has evolved since it was first recognized over 30 ...
Dry eye is a common ocular condition that results in eye pain and discomfort, visual disturbance and substantially affects quality of life.1 The incidence of dry eye is markedly increasing due to the expansion in the global internet network.2 The ...
Introduction In the recently updated Dry Eye WorkShop DEWS II report, dry eye is defined as a multifactorial disease of the ocular surface characterized by loss of homeostasis of the tear film, accompanied by ocular symptoms, tear film instability, hyperosmolarity, ...
Dry eye disease (DED) is a common ocular condition with a high impact on visual function and quality of life.1 However, DED is one of the most misdiagnosed diseases because of a delay in symptoms and clinical signs, and the ...
Dry eye disease (DED) is one of the most common conditions encountered by ophthalmologists, with up to 50% of patients reporting symptoms.1 For many decades, DED was thought to be a simple condition caused by reduction of the aqueous phase of ...
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
